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Abstract 
Background: Recurrent pregnancy loss (RPL) occurs in 3–5% in about 30% of cases no cause can be found. Women 
with RPL show higher prevalence of undiagnosed gut disorders. Furthermore, in endometrial tissues of RPL women, 
higher expression of pro-inflammatory cytokines and Nalp-3 inflammasome has been observed. Aim of this study was 
to investigate whether an abnormal gut permeability might occur in RPL women and allow passage into systemic 
circulation of pro-inflammatory molecules able to induce endometrial inflammation.
Methods: 70 women with idiopathic RPL and 30 healthy women were recruited at the Recurrent Pregnancy Loss 
Outpatient Unit of the Gemelli Hospital of Rome from March 2013 to February 2017. Enrolled women underwent 
51Cr-ethylene-diamine-tetraacetic acid absorption test to evaluate intestinal permeability. Sera obtained from enrolled 
women were analysed for lipopolysaccharide (LPS) by ELISA. Anxiety and depression state were evaluated by admin-
istering STAI-Y and Zung-SDS tests, respectively. Of all recruited individuals, 35 women with idiopathic RPL and 20 
healthy controls accepted to undergo diagnostic hysteroscopy and endometrial biopsy. Endometrial lysates were 
investigated for inflammasome Nalp-3 by Western blot analysis, and caspase-1, IL-1β and IL-18 by ELISA, respectively.
Results: Higher prevalence of abnormal intestinal permeability (P < 0.0001), increased circulating levels of LPS 
(P < 0.05), anxiety (P < 0.05) and depression (P < 0.05) were observed in RLP women compared to controls. Endometrial 
expression of Nalp-3, caspase-1 and IL-1β was significantly increased in RPL group (P < 0.0001; P < 0.05 and P < 0.001, 
respectively). IL-18 endometrial levels were not found to be higher in RPL cases. Statistically significant association 
between higher intestinal permeability and abnormally increased expression of endometrial Nalp-3, was observed in 
RPL (P < 0.01). Furthermore, higher LPS serum levels, a bacterial-derived activator of Nalp-3 complex, was shown to be 
statistically associated to abnormal endometrial expression of Nalp-3 inflammasome (P < 0.01) in RPL women.
Conclusions: In women with RLP, leaky gut might occur and allow passage into circulation of immune triggers, 
potentially able to elicit endometrial innate immune response and, thus, to contribute to miscarriage pathogenesis. 
Diagnosis and treatment of intestinal disorders underlying leaky gut might improve endometrial environment and 
pregnancy outcome.
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Background
Spontaneous pregnancy loss is a surprisingly common 
occurrence. Approximately 15–20% of all clinically rec-
ognized pregnancies result in spontaneous loss and it 
is believed that there are many more pregnancies, up to 
40–50%, that fail prior to being clinically recognized [1]. 
For a single isolated miscarriage within the 10th week 
of gestation no tests should be proposed to couples. A 
completely different clinical condition is represented by 
recurrent pregnancy loss (RPL), which occurs in 3–5% of 
all women and is defined by three consecutive pregnancy 
losses prior to 23 weeks of gestational age [1].
Using evidence-based tests for evaluation of couples 
with RPL, approximately 60% of couples will have an eti-
ology identified that could be associated with their losses. 
There are other factors, such as lifestyle factors, that 
may contribute to miscarriage and can be corrected or 
eliminated. These include maternal age, obesity, tobacco 
use and alcohol consumption. However, in about 40% of 
all RPL cases, after a complete screening for the known 
causes or predisposing factors, none of the above anoma-
lies can be found, identifying cases of idiopathic RPL [1]. 
Then, despite a thorough evaluation for RPL, not all cou-
ples will have answers to their dilemma.
It is known that RPL has a significant emotional impact 
on couples: early pregnancy loss is usually a shocking 
and traumatic event for women and their families. Dur-
ing the initial weeks following a loss, symptoms of grief 
may be impossible to distinguish from depression, and 
some women may continue to experience depressive 
symptoms for months [2]. Contributing to the distress 
experienced after miscarriage is the fact that society may 
not recognize the significance of the loss to the parents. 
Recently, Kolte and coauthors found that both psycho-
logical stress and major depression are significantly more 
common among women with RPL than in those with 
regular pregnancies [3]. From a pathogenic point of view, 
it is worth of note that there are evidences showing that 
depression and inflammation are intertwined and feeding 
off each other. This bidirectional loop, in which depres-
sion facilitates inflammatory responses and inflammation 
promotes depression may have consequences on health. 
Indeed, elevated inflammatory signaling disregulates 
neurotransmitter metabolism, impairs neuronal health, 
and alters neural activity in mood-relevant brain regions 
[4, 5]. In particular, it has been shown that pro-inflamma-
tory cytokines and lipopolysaccharide (LPS) may induce 
depressive symptoms [6–8]. On the other hand, depres-
sion is accompanied by an activation of the inflammatory 
response system. There is now evidence that intestinal 
mucosal dysfunction, characterized by an increased 
translocation of Gram-negative bacteria, called “leaky 
gut”, plays a role in the inflammatory pathophysiology 
of depression [9]. Furthermore, it is suggested that the 
increased LPS translocation, related to leaky gut, may 
induce an immune response and a systemic tissue inflam-
mation in patients with depression and specific sickness 
behaviour symptoms [10].
Concerning pregnancy loss, the endometrial expres-
sion of pro-inflammatory cytokines (IL-1β, TNF-α, IFN-
γ, and TGF-β1) has been shown to be up-regulated in 
women with idiopathic RPL compared with controls [11]. 
Moreover, recently, we observed an abnormal activation 
of the endometrial inflammasome Nalp-3, which repre-
sents the first line of defense against cellular stress and is 
a crucial component of innate immunity [12]. Upon acti-
vation of Nalp-3, apoptosis-associated speck-like protein 
containing a CARD (ASC) and caspase-1 are assembled 
and this multiprotein complex enables the caspase-1-me-
diated proteolytic processing of the pro-inflammatory 
cytokines (IL-1β and IL-18), generating their respective 
mature secretory forms. These events are necessary for 
the induction of further systemic responses and spread-
ing of inflammation [13, 14].
Currently, there are no available data in the interna-
tional literature on the role of abnormal intestinal per-
meability and RPL. Thus, since the clinical conditions 
characterized by increased intestinal permeability, also 
called “leaky gut”, may be related to the passage of path-
ogens-derived proteins (like LPS) into the blood circula-
tion, therefore inducing inflammasome activation, the 
aims of this study were:
a. to assess intestinal permeability and circulating LPS 
levels, as well as depression and anxiety levels, in 
women with RPL;
b. to investigate endometrial expression and activa-
tion of Nalp-3 in the same patients, correlating tissue 
inflammation to abnormality of intestinal permeabil-
ity and circulating levels of LPS.
Methods
Patients and samples
This case–control study was performed between March 
2013 and February 2017 at the Recurrent Pregnancy Loss 
Outpatient Clinic of the Gemelli Hospital of Rome, Italy. 
The study population included 70 women with history of 
idiopathic RPL with three or more spontaneous consecu-
tive pregnancy losses (≤ 12  weeks of gestation) clinically 
documented by ultrasonography [1] at least 6  months 
before the study and 30 healthy women with two or more 
previous uncomplicated term pregnancies (control group).
The inclusion criteria for both groups were as fol-
lows: caucasian, age ≤ 39  years, healthy, regular 
ovulatory cycles (28–32 days), normal serum levels of fol-
licle-stimulating hormone (FSH < 10 mIU/ml), luteinizing 
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hormone (LH < 10 mIU/ml) and anti-mullerian hormone 
(AMH > 2 ng/ml) on day 3 of the menstrual cycle, absence 
of abnormal ovarian and endometrial ultrasonographic 
features, no use of any contraceptive drugs or intrauter-
ine device in the last 6 months. Exclusion criteria were: 
smoking, alcohol consumption, presence of abnormali-
ties at the screening for RPL (anatomical abnormalities, 
endometrial cavity anomalies assessed by hysteroscopy, 
luteal phase deficiency, hyperprolactinemia, hyperin-
sulinemia or insulin resistance, endocrine disorders, 
vaginal infections, karyotype anomalies, thrombophilic 
disorders, autoimmune diseases), obesity, endometriosis, 
refusal to undergo intestinal permeability test, any patho-
logical conditions potentially interfering with intestinal 
permeability, like celiac disease or gluten sensitivity, his-
tory of viral hepatitis, diarrhea, diverticulosis, irritable 
bowel syndrome, inflammatory bowel diseases, or bari-
atric or other abdominal surgery, immunoglobulin A or 
immunoglobulins deficiency, impaired renal function, 
use of non-steroidal anti-inflammatory drugs, antibiotics, 
probiotics, or anti-secretory drugs within the 3  months 
preceding enrollment.
Samples collection
Peripheral blood samples (5  ml) from all RPL (n = 70) 
and healthy control women (n = 30) enrolled were col-
lected by vein puncture. Samples were spun at 3000 g at 
4 °C for 20 min, then the supernatant were aliquoted and 
stored at − 80 °C until use.
Thirty-five of seventy RPL women and twenty of thirty 
controls accepted a diagnostic mini-hysteroscopy dur-
ing the putative window of implantation (days 19th to 
24th), with endometrial biopsies. The biopsies timing was 
chosen according to the last menstrual period, monitor-
ing the follicle size by transvaginal ultrasound and then 
confirmed by histologic assessment [15]. All women 
were advised to avoid sexual intercourses from menses 
to planned hysteroscopic procedure. Serum progesterone 
and β-hCG levels were determined just before hysteros-
copy. Endometrial biopsy were performed using a 3-mm 
Novak curette, avoiding any contact between the curette 
and the vaginal walls, and then immediately washed in 
normal saline solution and stored at − 80 °C.
Biopsies were also analysed for Chlamydia trachoma-
tis, Mycoplasma, Ureaplasma urealyticum, Neisseria gon-
orrheae or yeast colonization. Patients with endometrial 
samples positive for pathogens colonization as well as 
those with evidence of chronic endometritis at hysteros-
copy were not included in the study.
Anxiety and depression state evaluation
Acute or stable anxiety of enrolled women was assessed 
by administration of the State-Trait Anxiety Inventory 
(STAI) Y test [16, 17], divided in two parts: the first eval-
uating the anxiety state by inquiring current emotional 
state asking twenty questions with responses ranging 
from ‘‘not at all’’ (score 1) to ‘‘extremely’’ (score 4) on a 
1–4 Likert scale. Total scores ranged from 20 to 80, with 
higher scores indicating higher degrees of state anxi-
ety. The second part of STAI Y test assesses trait anxiety 
by asking to subjects to describe how they usually feel. 
Twenty questions were asked to enrolled patients with 
responses ranging from ‘‘almost never’’ (score 1) to 
‘‘almost always’’ (score 4) on a Likert 1–4 scale. Higher 
scores reflected greater symptomatology and a suggested 
cutoff of 39 was established for clinically significant anxi-
ety (score: 40–50 mild; 50–60 moderate; > 60 severe [17]. 
STAI -Y questionnaires were completed in approximately 
20 min.
Depressive symptomatology was investigated with the 
use of the Zung Self-Rating Depression Scale (Z-SDS) 
[18], a short self-administered survey. The Z-SDS scale 
consists of 20 items rating the four common charac-
teristics of depression: (1) the pervasive effect, (2) the 
physiological equivalents, (3) other disturbances and 
(4) psychomotor activities. Each question is scored on a 
scale of 1–4 [corresponding to (1) a little of the time, (2) 
some of the time, (3) good part of the time and (4) most 
of the time]. The scores range from 25 to 100 to be set on 
a depression scale with higher scores reflecting greater 
symptomatology: 25–49 Normal Range; 50–59 Mildly 
Depressed; 60–69 Moderately Depressed; 70 and above 
Severely Depressed.
51Cr‑EDTA intestinal permeability test
51Cr-ethylene-diamine-tetraacetic acid (51Cr-EDTA) 
absorption test was performed in all patients enrolled to 
assess intestinal permeability as described elsewhere [19]. 
Enrolled women were all advised to avoid pregnancy dur-
ing the test month. After an overnight fast, patients were 
administered 0.37 MBq 51Cr-EDTA (Amersham Health, 
England, UK) in 10 ml water. The radiation dose admin-
istered was very low, analogue to the dose coming from 
a 2  days exposure to natural background radiation. The 
24-h urinary excretion of 51Cr-EDTA was analyzed using 
a γ-counter (LKB-Wallac 1282 Compugamma, Turku, 
Finland). Cr-EDTA clearance was calculated using the 
formula: 
 Results were expressed as fraction of the oral adminis-
tered dose and considered abnormal when ≥ 3% [19]. All 
women with abnormal intestinal permeability test (≥ 3%) 
underwent a gastroenterological evaluation and were 
then evaluated for serum levels of immunoglobulin (Ig) 
[(mean urinary counts× urinary volume)
× (standard counts× 50)− 1].
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A and E, anti-endomysial, anti-gliadin, anti-transglutam-
inase, perinuclear and cytoplasmic anti-neutrophil cyto-
plasmic antibodies (pANCA, and cANCA, respectively), 
Anti-Smooth Muscle and Anti–Saccharomyces cerevisiae 
antibodies (ASMA and ASCA, respectively) antibod-
ies, HLA DQ2-DQ8 haplotype and underwent lactose/
lactulose/sorbitol breath test and fecal calprotectin 
assay to exclude all known causes of increased intestinal 
permeability.
Assessment of circulating lipopolysaccharide levels
Sera from RPL and control women were thaw and ana-
lyzed for concentration of the Gram negative bacterial 
membrane component, LPS by LAL chromogenic end-
point assay (HyCult Biotechnology, Uden, Netherlands) 
according to the manufacturer’s instructions. Results 
were analysed by spectrophotometer (Titertek Multiscan 
plus Mk II plate reader ICN Flow Laboratories, Irvine, 
CA) measuring the absorbance at wavelengths of 450 nm.
Western blot analysis of endometrial Nalp‑3 expression
To investigate inflammasome Nalp-3 endometrial expres-
sion by Western blot, total cellular lysates obtained from 
endometrial biopsies of ten RPL and ten control women 
were separated by 10% SDS-PAGE electrophoresis under 
reducing conditions. After gel electrophoresis and trans-
fer of proteins to a nitrocellulose membrane, nitrocel-
lulose sheets were blocked at room temperature for 1 h 
in 5% non-fat dry milk and incubated overnight at 4  °C 
with a specific primary mouse monoclonal anti-Nalp-3 
antibody (ThermoFisher Scientific, Rockford, IL, USA). 
The membranes were then washed with PBST and incu-
bated with specific horseradish peroxidase-conjugated 
IgG diluted 1:2000 in PBST with 5% of non-fat dried 
milk. Bound secondary antibody was detected by chemi-
luminescence. Bands were analyzed by a Gel Doc 200 
Image Analysis System and quantified with the Quan-
tity One Quantitation Software (both from BioRad). As 
positive load control cytosolic β-actin band (42-kDa) was 
detected by a mouse monoclonal anti-human β-actin 
antibody (Sigma-Aldrich, St Louis, MO, USA).
Endometrial assessment of caspase‑1, IL‑1β and IL‑18
Caspase-1, IL-18 and IL-1β levels were measured in 
endometrial lysates from 35 RLP and twenty control 
women by a commercial enzyme-linked immunoas-
say (ELISA), according to manufacturer’s instructions 
(USCN Life Science Inc. and Cloud-Clone Corp. Hou-
ston, TX, USA). Briefly, 100  µl of samples or standard 
were added to each well coated with human monoclo-
nal anti-caspase-1 or IL-18 or IL-1β antibodies. After 
2 h of incubation at 37 °C, wells were washed and incu-
bated with a specific enzyme-linked polyclonal antibody, 
conjugated to horseradish peroxidase. Then, tetramethyl-
benzidine substrate solution was added to each well, and 
the color developed in proportion to the amount of the 
proteins bound in the initial step. The plate was read on 
a Titertek Multiscan plus Mk II plate reader (ICN Flow 
Laboratories, Irvine, CA) measuring the absorbance at 
wavelengths of 450 nm. Results were normalized for pro-
tein content of each sample.
Statistical analysis
Results are expressed as mean ± standard deviation (SD). 
Data were analyzed using one-way analysis of variance 
(ANOVA) followed by a post–hoc test (Bonferroni test) 
or Chi square according to type of variables. Statisti-
cal significance was determined at P < 0.05. Anxiety and 
depression state data are expressed as percentages and 
P value was determined at P < 0.05 (Student’s t test for 
unpaired data).
Results
Patients
Characteristics of the study population are summarized 
in Table 1. No significant differences in terms of age and 
BMI were observed between RLP and control women. 
Only three of seventy couples recruited in this study 
obtained their pregnancies by assisted reproductive tech-
nologies (ART). In particular, one couple underwent two 
in  vitro fertilizations (IVF) and one spontaneous preg-
nancy; the other two couples underwent an IVF and two 
spontaneous pregnancies. None of the couples enrolled 
in this study had conceived with donated oocytes. 
Because of the early gestational age of the spontaneous 
pregnancy losses, no information is available from any of 
Table 1 Clinical characteristics and  result of  clinical 
and  molecular tests administered to  RPL and  controls 
women
Results are expressed as average ± standard deviation (SD) or percentage (%) 
of total
CTR controls, n number, BMI body mass index, IVF in vitro fertilization, NS not 
statistically significant, RPL recurrent pregnancy loss, LPS lipopolysaccharide
CTR [n = 30] RPL [n = 70] P value
Age (years) ± SD 34.7 ± 6.7 37.3 ± 4.3 NS
BMI (Kg/m2) 21.9 ± 2.8 24.4 ± 3.4 NS
IVF (n) 0.0 (0.0%) 3.0 (4.3%) NS
Intestinal permeability (%) ± SD 2.2 ± 0.3 6.4 ± 0.7 < 0.0001
Serum LPS levels (EU/ml) ± SD 0.3 ± 0.1 0.9 ± 0.1 < 0.05
Anxiety state (STAI-Y1) (%) 35.0 87.0 < 0.05
Anxiety trait (STAI-Y2) (%) 31.0 60.0 < 0.05
Depression state (Zung scale) 
(%)
24.0 48.0 < 0.05
Abnormal endometrial Nalp-3 
expression (%)
0.3 85.7 [n = 35] < 0.0001
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the couples enrolled in the RPL group about the chromo-
somal results on the product of conception.
RPL was associated with abnormal intestinal permeability
Intestinal permeability of enrolled patients was assessed 
by 51Cr-EDTA absorption test. We observed a higher 
prevalence of abnormal intestinal permeability in RPL 
patients compared to the control group (Table 1). At gas-
trointestinal evaluation, none of women with increased 
intestinal permeability referred clear symptoms of gas-
trointestinal diseases. None of the recruited women 
showed any abnormal levels of immunoglobulin (Ig) A or 
E, or any positivity for anti-endomysial, anti-gliadin, anti-
transglutaminase antibodies, HLA DQ2-DQ8 haplotype, 
lactose/lactulose/sorbitol breath tests, fecal calprotectin 
assay, pANCA, cANCA, ASCA or ASMA antibodies.
RPL women showed higher circulating levels 
of lipopolysaccharides
Assessment of serum LPS levels revealed significantly 
increased circulating levels of LPS in women with RPL 
compared to the controls (P < 0.05; Table 1). The cut off 
for defining abnormal LPS circulating levels was estab-
lished to be > 2SD of the LPS average levels in a healthy 
population (0.4 EU/ml).
Women with RPL showed a higher prevalence 
of depression and anxiety
Results of the psychological tests are reported in Table 1. 
Overall, RPL patients showed more symptoms of depres-
sion and anxiety than control healthy subjects.
Eighty-seven percent of the RPL women, compared 
with 35% of the control group, had STAI-Y1 (state anxi-
ety) scores > 39 (95% mild and 5% moderate for the 
RPL group; 90% mild and 10% moderate for the control 
group).
Sixty percent of the RPL women, compared with 31% of 
the control group, had STAI-Y2 (trait anxiety) scores > 39 
(79% mild and 21% moderate for the RPL group; 89% 
mild and 11% moderate for the control group).
Forty-eight percent of the RPL women, compared with 
24% of the healthy control group, had a score > 50 on the 
Z-SDS test (40% mildly depressed and 8% moderately 
depressed; P < 0.05).
Endometrial Nalp‑3 inflammasome was over expressed 
and activated in RPL
Western Blot analysis showed a significant increase of 
Nalp-3 proteins expression in endometrial tissues of 
women with idiopathic RPL compared to the controls 
(P < 0.0001) (Table 1 and Fig. 1a). The cut off for defining 
Nalp-3 endometrial expression to be abnormal was > 2SD 
of endometrial Nalp-3 average expression of the control 
population (3000 O.D.).
We also examined the levels of caspase-1 in endome-
trial lysates obtained from hysteroscopic biopsies by 
ELISA. As shown in Fig. 1b, increased levels of caspase-1 
were shown in the RPL women compared to the controls 
(P < 0.05). Finally, through an ELISA assay, we evalu-
ated the levels of IL-1β and IL-18 in endometrial lysates 
obtained from the controls and RPL women. Significantly 
increased levels of pro-inflammatory cytokine IL-1β 
(Fig. 1c), but not of IL-18 (Fig. 1d), were found by ELISA 
in endometrial tissues of the RPL women compared to 
the controls (P < 0.001).
Abnormal intestinal permeability and circulating LPS levels 
were associated with increased expression of endometrial 
Nalp‑3 in women with RPL
When analyzing statistical correlation between abnormal 
intestinal permeability, LPS serum levels and endometrial 
Nalp-3 expression and activation in patients with RPL, we 
observed a clear association between abnormal intestinal 
permeability and endometrial Nalp-3, suggesting a pos-
sible cause-effect relation between passage of inflamma-
tory stimuli through the gut barrier and the activation of 
endometrial innate immunity (Table 2). Neither intracel-
lular activation of Nalp-3 cascade (caspase-1) nor secre-
tion of the pro-inflammatory specific IL1β and IL-18 
were observed to be statistically associated to abnormal 
intestinal permeability or LPS (data not shown). No sta-
tistical correlation was found between intestinal perme-
ability abnormality and increased LPS serum levels in 
patients with RPL (Table  2). Significant correlation was 
observed between LPS serum levels and Nalp-3 endome-
trial expression in patients with RPL (P < 0.01) (Table 3). 
Abnormal intestinal permeability and circulating LPS 
levels are not associated to anxiety and depression state 
in women with RPL
Abnormal intestinal permeability was not associated 
to anxiety state or trait, or depression (Table  2). RPL 
women with higher circulating levels of LPS did not 
show significant higher prevalence of anxiety and depres-
sion state compared to once with normal levels of serum 
LPS (Table  3). A significant association was found only 
between abnormal serum levels of LPS and anxiety trait 
(Table  3). As a whole, abnormal intestinal permeability 
and serum LPS levels do not seem to be related to psy-
chological disorder in a strong cause-effect relationship.
Discussion
The main finding of the present study is the higher preva-
lence of abnormal intestinal permeability in patients with 
idiopathic RPL. In the same population, we detected 
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higher plasma levels of LPS, an immunogenic parietal 
fragment from Gram-negative bacteria. Furthermore, 
consistently with a previous study [12], we confirmed an 
increased expression and activation of Nalp-3 inflam-
masome proteins in the human endometrium of women 
with RPL, as well as an increased caspase-1 activation 
and secretion of the pro-inflammatory cytokine IL-1β. 
Interestingly, for the first time, we could link the endome-
trial Nalp-3 inflammasome over expression and activa-
tion with leaky gut. Based on our data, we can speculate 
that in RPL women bacterial components might enter 
systemic circulation through a damaged intestinal bar-
rier and induce inflammatory cytokines production in 
endometrial tissues, via inflammasome Nalp-3 activation. 
The lack of significant correlation between increased 
intestinal permeability and LPS might be explained: (a) 
because of the small number of patients recruited; (b) for 
the heterogeneity of gut microbiota composition in our 
population; (c) because not only bacteria-derived mol-
ecules but also other molecules coming from the external 
environment (food, chemicals, drugs, etc.) might cross 
gut barrier and stimulate Nalp-3 inflammasome. Thus, 
we hypothesize that leaky gut, occurring for reasons that 
we cannot explain yet, allows the passage of antigens 
through the intestinal barrier, that might elicit innate 
immunity in endometrial tissue. Hence, when there is an 
increased intestinal permeability and/or when higher cir-
culating levels of LPS are detected in RPL subjects, there 
might be a higher risk of endometrial inflammation and 
reproductive disorders.
The occurrence of cross-talk between the gut and the 
reproductive system may be an intriguing hypothesis that 
could suggest a possible new approach to a specific group 
of patients with idiopathic RPL. Evidence supporting a 
role for the intestinal-endometrial axis in the pathogen-
esis of early pregnancy complications has being slowly 
accumulating over the most recent years [20, 21]. The 
most studied pathogenic model is celiac disease (CD). CD 
has been related to augmented intestinal permeability 
due to the ability of gliadin to disrupt intestinal epithelial 
tight junction proteins including zonulin-1, claudin-1 and 
occludin, all polyamines with a pivotal role in the control 
Fig. 1 a Representative Western blot analysis of endometrial Nalp-3 inflammasome expression. Endometrial lysates from RPL (n = 10) showed 
significantly higher expression of Nalp-3 compared to controls (n = 10) (O.D optical density). Histograms show average ± SD of three independent 
experiments. b, c Endometrial Nalp-3 inflammasome activation assessed by ELISA. Significantly higher levels of endometrial caspase-1 (b) and Il-1β 
(c) were observed in RPL patients (n = 35) compared to controls (n = 20). Histograms show average ± SD of three independent experiments. CTR: 
controls. Statistical significance versus CTR: *P < 0.05; **P < 0.01; ***P < 0.0001. CTR: controls
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of intestinal barrier function, inducing the leaky gut syn-
drome [22, 23]. Several studies reported an increased 
risk of reproductive failures including recurrent miscar-
riage in women with CD. In particular, according to a 
previous meta-analysis, women experiencing RPL have 
an Odds Ratio (OR) for CD of 5.82 (95% CI 2.30–14.74) 
and the risk of miscarriage in women with CD is signifi-
cantly higher with an RR of 1.39 (95% CI 1.15–1.67) [20]. 
As a whole, we can hypothesize that recovering intesti-
nal barrier might reduce tissue inflammation and take 
the endometrium back to a favorable environment for 
implantation and pregnancy development.
Finally, the role of anxiety and depression in RPL 
patients has yet to be clarified. We did not find a strong 
correlation among depression/anxiety state and intestinal 
permeability or abnormal LPS levels but only an associa-
tion between abnormal LPS circulating levels and anxi-
ety trait. However, in our population of RPL, we found a 
higher prevalence of self-reported stress and moderate/
severe depression. Previous studies on depression and 
RPL have been few, using a variety of scales and lacking 
an appropriate comparison group [24–27]. The reported 
prevalence of depression varies considerably across 
studies, ranging from 15 to 33% [24–27]. Psychological 
stress and RPL have been not extensively studied, but 
one case–control study described a significantly higher 
psychological stress total score among 45 patients with 
RPL, compared with 40 controls [10]. Interestingly, it 
has been demonstrated that the gut-brain axis involves 
bidirectional communication between the central nerv-
ous system and the gastrointestinal tract via neurocrine 
and endocrine signaling pathways [28]. Indeed, physical 
and psychological stressors can alter the gut microbiota’s 
composition and metabolic activities, and signals pro-
duced by the gut microbiota can in turn affect the brain 
and emotional responses [29]. Moreover, depression can 
promote intestinal permeability leading to leaky gut. 
Interestingly, depressed patients have been found to have 
higher antibodies against gut bacteria than healthy sub-
jects [30]. In another study, patients with major depres-
sion showed higher circulating levels of 16S rDNA, a 
marker of bacterial translocation, compared with healthy 
subjects, and the magnitude was correlated with depres-
sive symptom severity [31]. As a whole, it is widely 
accepted that increased bacterial translocation could play 
a role in the inflammatory pathophysiology of depression 
by inducing acute inflammatory responses and contrib-
uting to subchronic inflammation [32]. To support these 
evidences, LPS has been shown to elicit depressive and 
anxious behaviors in rats [33].
Conclusions
Leaky gut, depressive symptoms and RPL are intertwined 
conditions but it is difficult to establish which cause-
effect relationship might occur. This is the first study 
detecting abnormal intestinal permeability in women 
with RPL. According to our hypothesis, in this popula-
tion an abnormal intestinal permeability, worsened or 
Table 2 Statistical correlation between  abnormal intesti‑
nal permeability and circulating levels of LPS, endometrial 
Nalp‑3 inflammasome expression, anxiety and depression 
state in women with RPL
Results are expressed as percentage (%) of total. LPS lipopolysaccharide. P < 0.05. 
n number
Intestinal permeability P value
Normal Abnormal
LPS serum levels [n = 70]
 Normal 4 (5.7%) 10 (14.3%) 0.8
 Abnormal 5 (7.1%) 51 (72.9%)
Abnormal endometrial Nalp-3 expression [n = 35]
 Normal 3 (8.6%) 2 (5.7%) < 0.01
 Abnormal 4 (11.4%) 26 (74.3%)
Anxiety state (STAI-Y1) [n = 70]
 Absent 1 (1.4%) 6 (8.6%) 0.9
 Present 1 (1.4%) 62 (88.6%)
Anxiety trait (STAI-Y2) [n = 70]
 Absent 1 (1.4%) 12 (17.2%) 0.3
 Present 1 (1.4%) 56 (80.0%)
Depression state (Zung scale) [n = 70]
 Absent 1 (1.4%) 22 (31.4%) 0.6
 Present 1 (1.4%) 46 (65.8%)
Table 3 Statistical correlation between  LPS serum levels 
and  endometrial Nalp‑3 inflammasome expression, anxi‑
ety and depression state in women with RPL
Results are expressed as percentage (%) of total. LPS lipopolysaccharide. P < 0.05. 
n number
LPS levels P value
Normal Abnormal
Nalp-3 expression [n = 35]
Normal 7 (20%) 1 (2.9%) < 0.01
Abnormal 8 (22.9%) 19 (54.2%)
Anxiety state (STAI-Y1) [n = 70]
Absent 1 (1.4%) 5 (7.1%) 0.8
Present 18 (25.8%) 46 (65.7%)
Anxiety trait (STAI-Y2) [n = 70]
Absent 1 (1.4%) 15 (21.4%) < 0.05
Present 15 (21.4%) 39 (55.8%)
Depression state (Zung scale) [n = 70]
Absent 10 (14.3%) 10 (14.3%) 0.6
Present 10 (14.3%) 40 (57.1%)
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caused ex novo by a depressive or anxious state, might 
allow passage of immune triggers from external environ-
ment, not only of bacterial derivation, that might elicit 
innate immune response, leading to endometrial inflam-
mation and, thus, potentially to miscarriage.
More studies are needed to confirm our hypothesis 
and define the pathogenic mechanisms of inflammation-
induced miscarriage. Furthermore, the beneficial effect of 
recovering intestinal barrier function in RPL women, as 
well as psychological health, on subsequent obstetric out-
comes should be evaluated.
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